I. Dayan

Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes

L. Carmel-Goren, M. Baru, R. Yatuv, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

A modified chromogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C)

M. Baru, R. Yatuv, I. Dayan, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF

M. Baru, R. Yatuv, I. Dayan, 2010, Expert opinion on drug delivery.

Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy

Yechezkel Barenholz, Y. Barenholz, J. Spira, 2005, Thrombosis and Haemostasis.

Enhancement of haemostatic efficacy of plasma‐derived FVIII by formulation with PEGylated liposomes

M. Baru, I. Dayan, M. Robinson, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross‐over, phase I/II study

J. Spira, N. Zozulya, O. Plyushch, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Binding of proteins to PEGylated liposomes and improvement of G-CSF efficacy in mobilization of hematopoietic stem cells.

L. Carmel-Goren, M. Baru, R. Yatuv, 2009, Journal of controlled release : official journal of the Controlled Release Society.